Cancer BiologybioRxivPreprint
Beyond PAM50: Unsupervised Discovery of Anomalous Subgroups in Breast Cancer
This study identifies immune-suppressed subgroups in breast cancer using unsupervised anomaly detection, revealing potential clinical relevance.
DOI 10.1101/2025.05.11.653361